Company Wuhan General Group (China), Inc.
Equities
WUHN
US9825691051
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -99.00% |
Business Summary
Number of employees: 700
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Cannabinoids and Psilocybin Medical Research
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -57.40% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -57.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Robinson
FOU | Founder | - | 18/07/88 |
Willem Jonker
DFI | Director of Finance/CFO | - | 04/10/20 |
Riyad Domingo
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/21 |
Chief Tech/Sci/R&D Officer | - | 21/01/19 | |
Warren Kansley
SAM | Sales & Marketing | - | - |
Robert Simbowe
PRN | Corporate Officer/Principal | - | 23/05/21 |
Rameez Adair
PRN | Corporate Officer/Principal | - | 02/06/20 |
Corporate Officer/Principal | - | 02/06/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 21/01/19 | |
Jeff Robinson
FOU | Founder | - | 18/07/88 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 6,354,078 | 0 | 0 | 76.65 % |
Stock B | 1 | 55,149,662 | 42,271,310 ( 76.65 %) | 0 | |
Stock C | 0 | 6,241,453 | 0 | 0 |
Company contact information
Wuhan General Group (China), Inc.
Unit 01, Mason's Press 7 Ravenscraig Road
7925, Cape Town
+
http://www.m2bio.coSector
1st Jan change | Capi. | |
---|---|---|
-99.00% | 55 | |
+29.79% | 48.16B | |
-0.36% | 41.73B | |
+43.62% | 41.03B | |
-5.31% | 28.77B | |
+11.11% | 25.59B | |
-22.38% | 18.96B | |
+8.70% | 12.92B | |
+28.75% | 12.03B | |
-2.22% | 11.77B |
- Stock Market
- Equities
- WUHN Stock
- Company Wuhan General Group (China), Inc.